Gabelli Healthcare & WellnessRx Trust reporting persons associated with Saba Capital Management, L.P. disclosed open-market purchases of the fund's common stock.
On December 16, 2025, they purchased 11,312 common shares at $9.37 per share, and on December 17, 2025 they purchased an additional 4,084 shares at $9.36. Following these transactions, they beneficially owned 2,118,201 shares of common stock held indirectly.
Gabelli Healthcare & WellnessRx Trust director and adviser control person Mario J. Gabelli reported an open-market purchase of common shares. On 12/03/2025 he bought 2,500 common shares at a price of $9.6877 per share, a transaction reported as a purchase. Following this trade, he directly holds 239,425 common shares.
In addition to his direct holdings, the filing lists indirect beneficial ownership positions: 312,226 shares through GGCP, Inc., 8,000 shares through Associated Capital Group, Inc., 6,380 shares through GPJ Retirement Partners, and 3,000 shares in a trust account established by Mr. Gabelli. For several of these entities he notes that he owns less than 100% and disclaims beneficial ownership of shares beyond his indirect pecuniary interest.
Gabelli Healthcare & WellnessRx Trust director reports multiple share sales. A director of Gabelli Healthcare & WellnessRx Trust (ticker GRX) filed a Form 4 disclosing a series of open-market sales of common shares, par value $0.001, during August, September, and October 2025. Reported transactions include several sales of 2,000 shares and smaller blocks of 200 to 1,000 shares at prices around $9.1 to $9.5 per share. After these transactions, the reporting person directly beneficially owned 2,185 common shares.
Saba Capital Management, L.P., a 10% owner of Gabelli Healthcare & WellnessRx Trust (GRX), reported a recent insider purchase. On 11/25/2025, the firm bought 14,451 shares of GRX common stock in an open-market transaction coded "P" at a price of $9.62 per share. After this trade, Saba Capital Management, L.P. indirectly beneficially owned 2,102,805 GRX shares, as reported on this Form 4.
Mario J. Gabelli reported purchasing 1,800,000 Series G Cumulative Preferred Shares of Gabelli Healthcare & WellnessRx Trust at $10.1791 on 10/30/2025.
After the trade, reported beneficial ownership totaled 2,000,000 shares indirect via Associated Capital Group, Inc., 400,000 shares indirect via GAMCO Investors, Inc., and 200,000 shares held directly.
Gabelli-affiliated entities filed an amended Schedule 13D reporting beneficial ownership of 3,514,000 Series G preferred shares of Gabelli Healthcare & WellnessRx Trust (GRX), representing 64.73% of the 5,428,514 shares outstanding as reported by the issuer.
The filing notes a recent transaction: the Gabelli Foundation purchased 200,000 Series G shares on October 28, 2025 at $10.0476 per share in a private placement, for approximately $2,009,520. Reported holdings include Associated Capital Group with 2,200,000 shares (40.53%), GAMCO Investors with 400,000 (7.37%), Mario J. Gabelli with 400,000 (7.37%), and the Gabelli Foundation with 514,000 (9.46%).
Gabelli-affiliated filers amended their Schedule 13D on Gabelli Healthcare & WellnessRx Trust’s preferred shares, disclosing an aggregate beneficial ownership of 3,314,000 shares, or 61.05% of the 5,428,514 shares outstanding as reported by the issuer.
The group reported using approximately $18,322,400 to purchase additional Series G cumulative preferred shares in a private placement. Within the aggregate, Associated Capital Group, Inc. holds 2,200,000 shares (40.53%), GAMCO Investors, Inc. holds 400,000 (7.37%), Mario J. Gabelli holds 400,000 (7.37%), and the Gabelli Foundation, Inc. holds 314,000 (5.78%). A disclosed transaction shows 1,800,000 Series G shares purchased at $10.1791 on 10/30/2025 in a private placement.
Gabelli Healthcare & WellnessRx Trust (GRX) reported an insider transaction on a Form 4. A reporting person purchased 20,808 shares of common stock on 10/23/2025 at a price of $9.28 per share.
Following this open-market purchase (transaction code P), the reporting person’s indirect beneficial ownership stands at 2,088,354 shares.
Gabelli Healthcare & WellnessRx Trust (GRX) reported insider activity on a Form 4. The reporting person disclosed two open‑market purchases of common stock: 6,122 shares at $9.29 on 10/21/2025 and 1,053 shares at $9.31 on 10/22/2025. Following these transactions, the reporting person beneficially owns 2,067,546 shares, held indirectly.
Saba Capital filed Amendment No. 3 to Schedule 13D on GRX (The Gabelli Healthcare & WellnessRx Trust), reporting beneficial ownership of 2,054,555 common shares, representing 13.3% of the class.
The filing states approximately $19,801,664 was paid to acquire the reported shares. The percentage is based on 15,447,824 shares outstanding as of 6/30/25, per the issuer’s N‑CSRS. Voting and dispositive power are listed as shared for the full amount. The amendment notes the event date triggering the filing was 10/16/2025 and updates Items 3, 5, and 7.
Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein are the reporting persons. The filing also indicates the positions are held across funds and accounts advised by Saba, which have the right to receive dividends and sale proceeds.